Blog - Page 2535 of 5766

ThursdayAug 10, 2017 10:54 am

Algae Dynamics Corp. (ADYNF) Hoping US Senate Bill Decriminalizing Marijuana Will Be Successful

Proposed legislation would remove cannabis from the list of Schedule I controlled substances. If successful, it would pave the way for the Canadian company to enter the U.S. market. Unique combination of algae and cannabis oils targeting cancer and mental health disease, making Algae Dynamics a lucrative opportunity for investors. A bill looking to decriminalize marijuana all over the country has recently been introduced in the U.S. Senate, giving fresh hope to legal cannabis businesses that they will be able to expand operations and access federal protections and banking solutions. The bill, titled the Marijuana Justice Act, was introduced by…

ThursdayAug 10, 2017 10:22 am

Global Payout, Inc. (GOHE) is “One to Watch”

Global Payout, Inc. (OTC: GOHE) provides comprehensive payment solutions that can be fully customized for virtually any domestic and international organization distributing money worldwide. The company is committed to enabling global access to technology for optimizing financial transactions and delivering a global financial eco-system with top-tier banking institutions and the highest level financial technology partnerships. Today, more than ever before, commercial enterprises and government institutions need powerful financial technology solutions that have the flexibility to deliver innovative customer centric services and drive operational efficiency gains throughout the organization. The Global Reserve Platform is Global Payout’s fully configurable “banking-in-a-box” web-based platform…

ThursdayAug 10, 2017 9:35 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) CEO Discusses Company’s Progress in Interview

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a company engaged in licensing proprietary technology for the delivery of bioactive compounds, this morning announced that its chief executive officer, Chris Bunka, was featured in a recent interview on the Uptick Network Stock Day Radio Show. Bunka leveraged the platform to discuss Lexaria’s overall accomplishments in the past three months, as well as the company’s expectations for profitability moving forward. He notes that ongoing research and development programs could open both the NSAID and Nicotine markets to Lexaria, providing an opportunity to significantly increase corporate revenues and facilitate further expansion. “In the…

ThursdayAug 10, 2017 9:09 am

AppSwarm, Inc. (SWRM) Ahead of the Game as It Seeks to Increase Choice for More than 2 Billion Players

Incubator for developers of mobile apps Digital game industry continues to grow Mobile app development across Apple, RIM, Google and Microsoft Platforms If you think that movies are big business, you’re right. Then what would you say about the digital game industry, which by most accounts is twice or three times as large? Out of a global population of some 7.5 billion, about 2.2 billion (29%) play ‘video’ games. That’s good, since, according to one academic report, ‘playing video games can boost brain power’. So playing digital games is smart as well as fun, which is why AppSwarm, Inc. (OTC:…

WednesdayAug 09, 2017 1:59 pm

ChineseInvestors.com, Inc. (CIIX) Seen Benefitting from Senate Committee Vote for Amendment Protecting Legal Cannabis

Unclear whether amendment will survive in final appropriations bill, but Congressional vote sends message to Attorney General Jeff Sessions CIIX is expanding in global market with online cannabidiol store in Shanghai, China, and brick-and-mortar unit to open in San Gabriel, California Consilium Global Research estimates that CIIX will outperform cannabis market to achieve revenues of $14.8 million by FY 2020 ChineseInvestors.com, Inc. (OTCQB: CIIX) and other cannabis companies were overjoyed by the July 27 affirmative voice vote by the Senate Appropriations Committee to approve an amendment to a “2018 Commerce, Justice and Science Bill” that bars the federal government from…

WednesdayAug 09, 2017 12:13 pm

ProBility Media Corp. (PBYA) Recent Acquisitions, New Service Offerings Position Company as E-Learning Market Leader

Strategic acquisitions driving company growth, offering unique opportunities for investment Company completed Cranbury International acquisition, expanding portfolio and international reach Product roster further expands with VR training materials and 3D animations Innovative EdTech company ProBility Media Corp (OTCQB: PBYA) is solidifying its position on the e-learning and training market via a series of recent acquisitions and new service and product offerings. With a declared goal of building the first full-service career advancement and training brand for skilled trades, ProBility is offering a combination of training and educational materials with virtual reality-based products for modeling training and 3D animation to an…

WednesdayAug 09, 2017 11:10 am

Medical Innovation Holdings, Inc. (MIHI) Transforming Telemedicine

Current telemedicine model is fragmented with little to no up sell Millions of Americans live in areas with little to no comprehensive health care MIHI building nationwide telemedicine network, making MIHI sole practitioner to millions An estimated 80 million Americans live in rural areas where access to medical services is extremely limited. Identified as Medically Underserved Areas by the government, these regions suffer from a chronic shortage of not only primary care physicians but, even more critically, specialty care physicians. Targeting these medically underserved areas, Medical Innovation Holdings, Inc. (OTC: MIHI) intends to deliver much needed medical care while simultaneously…

WednesdayAug 09, 2017 9:06 am

QualityStocksNewsBreaks – Patriot One Technologies’ (TSX.V: PAT) (OTCQB: PTOTF) PATSCAN CMR Attains Milestone in Certification Pathway

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) this morning announced that its award-winning PATSCAN CMR™ (Cognitive Microwave Radar) concealed weapons detection system has met Federal Communications Commission (FCC) and Industry Canada (IC) regulatory requirements, as verified through a series of tests by an accredited third party laboratory. “This is significant news for our Company,” Dinesh Kandanchatha, CTO of Patriot One Technologies, stated in the news release. “Many companies have found meeting FCC and IC requirements to be a daunting challenge. Since we began operations last November we have worked relentlessly to identify, execute and address a lengthy checklist of…

TuesdayAug 08, 2017 4:06 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Praised in Technical420 Article

Lexaria Bioscience Corp. featured in a Technical420 article praising the company’s recent developments Lexaria is improving and strengthening patent portfolio; 19 patent applications are pending in more than 40 countries Company executes partnership with NeutriSci International; joint venture allows LXRP to enter Asian market Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), an innovative company licensing proprietary technology for the delivery of bioactive compounds including cannabinoids, is a “plant-to-bloodstream” company expected to draw investors in the cannabis marketplace. Lexaria has patented and licenses a novel delivery system that infuses organically sourced hemp oil into the molecules of other substances. Cannabidiol, noted…

TuesdayAug 08, 2017 12:03 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Findings Set Stage for Future Cannabinoid Compound Studies

Fundamental value drivers of InMed Pharmaceuticals are its drug development pipeline and proprietary biosynthesis technology in cannabinoid manufacturing Biopharmaceutical company already has two drug candidates – INM-085 and INM-750 – in the multi-billion dollar ocular and dermatology markets INM-085 and INM-750 target markets valued in excess of $5 billion and $1 billion, respectively InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) study, which generated an article published in the European Journal of Pain (http://dtn.fm/UMfe5), sets the stage for more research into how a topically-applied drug can provide relief of chronic or acute pain without central side effects, according to Dr. Sazzad…

Site Search

Company Search